COMMUNIQUÉS West-GlobeNewswire

Mesoblast and JCR Pharmaceuticals Expand Japan License Agreement to Use of Mesenchymal Stem Cells in Newborns With Insufficient Blood Flow to the Brain
11/06/2019
NEW YORK and MELBOURNE, Australia, June 11, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO) today announced it has expanded its partnership with JCR Pharmaceuticals Co. Ltd. in Japan to the use of [...]
Change in Orion Corporation's holding of treasury shares
11/06/2019
ORION CORPORATION STOCK EXCHANGE RELEASE 11 JUNE 2019 at 11.45 EEST Change in Orion Corporation's holding of treasury shares A total of 238 Orion class B shares have been returned free of consideration to Orion [...]
Philips spotlights AI-powered health information management solutions at HIMSS & Health 2.0 Europe
11/06/2019
June 11, 2019 Intelligent Connected Care solutions feature expansion of Philips IntelliSpace Enterprise Edition, Tasy EMR and Tele-ICU technology into Europe Amsterdam, the Netherlands and Helsinki, Finland – Royal [...]
Philips’ Future Health Index 2019 report focuses on the role digital health technology plays in improving both the clinician and patient experience
11/06/2019
June 11, 2019 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the publication of its Future Health Index (FHI) 2019 report: ‘Transforming [...]
Genmab Signs Agreement with Janssen for Next-Generation CD38 Antibody, HexaBody®-CD38
11/06/2019
Company Announcement Genmab signs agreement with Janssen Biotech, Inc. to collaborate exclusively on next-generation CD38 antibody product, HexaBody ® -CD38, incorporating Genmab’s proprietary HexaBody technology New [...]
ONCURIOUS NV Receives Project Grant from VLAIO to Progress its Pipeline of Next Generation Cancer Immunotherapies
11/06/2019
Leuven, Belgium 11 June 2019 - ONCURIOUS NV , a Belgium-based biotech company focusing on the development of innovative oncology treatments, today announces that it has received from Flanders Innovation and [...]
FDA grants Roche’s Polivy accelerated approval for people with previously treated aggressive lymphoma
11/06/2019
New targeted medicine shown to improve clinical outcomes in people with relapsed or refractory diffuse large B-cell lymphoma compared to a commonly used regimen First-in-class antibody-drug conjugate that specifically [...]
Servier and Galapagos complete enrollment of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
11/06/2019
Mechelen, Belgium and Paris, France, 11 JUNE 2019, 07.00 CET - Servier and Galapagos NV (Euronext & NASDAQ: GLPG) completed recruitment for their ROCCELLA Phase 2 trial with GLPG1972/S201086, ahead of schedule. [...]
Changes in Roche's Board of Directors and Corporate Executive Committee
11/06/2019
Basel, 11 June 2019 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Peter Voser (61), a member of the Board of Directors of Roche Holding Ltd since 2011, has decided to step down as a member of the Board of [...]
OSE Immunotherapeutics Receives U.S. Patent Notice of Allowance for Use of Tedopi® to Treat Brain Metastasis
11/06/2019
NANTES, France, June 11, 2019 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN: FR0012127173; Mnémo: OSE) today announced that the United States Patent and Trademark Office (USPTO) has issued the notice of allowance for [...]
Beyond Skin Cancer Awareness Month: Fine Arts Skin & Laser Urges Sun Safety
11/06/2019
Dover and Akron-area facial plastic surgeon Dr. David Hartman and his team outline skin cancer prevention tips DOVER, Ohio, June 10, 2019 (GLOBE NEWSWIRE) -- May is over—but even though Skin Cancer Awareness Month of [...]
Zealand Pharma presents dasiglucagon pivotal Phase 3 trial data at the 79th Scientific Sessions of the American Diabetes Association (ADA)
11/06/2019
Press release – No. 14 / 2019 Zealand Pharma presents dasiglucagon pivotal Phase 3 trial data at the 79th Scientific Sessions of the American Diabetes Association (ADA) The pivotal Phase 3 trial demonstrates that a [...]
Real-World Data from Guardian(TM) Connect and Sugar.IQ(TM) Reveal Improved Diabetes Outcomes
10/06/2019
Sugar.IQ Insights Viewed as Helpful and Enable Users to Avoid Diabetes-Related Events up to Four Hours in Advance DUBLIN and SAN FRANCISCO - June 10, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical [...]
HEXO Corp to announce third quarter fiscal 2019 results and webcast
10/06/2019
GATINEAU, Quebec, June 10, 2019 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO ; NYSE-A: HEXO ) will release its financial results for the third quarter fiscal 2019 ended April 30 after markets close [...]
HEXO Corp annonce ses résultats du troisième trimestre de l’exercice 2019 et une diffusion web
10/06/2019
GATINEAU, Québec, 10 juin 2019 (GLOBE NEWSWIRE) -- HEXO Corp (« HEXO » ou la « Société ») (TSX: HEXO ; NYSE-A: HEXO ) annoncera ses résultats financiers du troisième trimestre de l’exercice 2019, clos le 30 avril, après [...]
33 Genesis HealthCare Centers Earn 2019 Bronze National Quality Awards
10/06/2019
KENNETT SQUARE, Pa., June 10, 2019 (GLOBE NEWSWIRE) -- Genesis HealthCare , one of the largest post-acute care providers in the United States, today announced that 33 of its affiliated skilled nursing / senior living [...]
Geron to Webcast KOL Event on June 25, 2019
10/06/2019
MENLO PARK, Calif., June 10, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that the Company will webcast an event on June 25, 2019, featuring key opinion leaders (KOLs) who are authors of [...]
PLx Pharma Inc. to Present at JMP Securities Life Sciences Conference
10/06/2019
HOUSTON, June 10, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company initially focused on developing its clinically validated and patent- [...]
Kezar Life Sciences to Host Conference Call and Webcast at the EULAR 2019 Annual Meeting to Discuss Results of First in Patient Study with KZR-616
10/06/2019
Conference call and webcast scheduled for Thursday, June 13, 2019 at 4:05 p.m. EDT SOUTH SAN FRANCISCO, Calif., June 10, 2019 (GLOBE NEWSWIRE) -- Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology [...]

Pages